stella
beta
Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer — Stella
Recruiting
Back to Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
View full record on ClinicalTrials.gov